Your browser doesn't support javascript.
loading
V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy.
Zhou, Xia; Khan, Sohail; Huang, Dabing; Li, Lu.
Affiliation
  • Zhou X; Department of Oncology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Khan S; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Huang D; Department of Oncology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Li L; Department of Oncology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Front Immunol ; 13: 938470, 2022.
Article in En | MEDLINE | ID: mdl-36189222
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Neoplasms Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Neoplasms Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Country of publication: